Sri Wahyuni
Faculty of Health Science, Universitas Muhammadiyah Surabaya, Indonesia

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Comorbid Diabetes Mellitus in Patients with Coronavirus Disease 2019: A Literature Review Suyatno Hadi Saputro; Ratna Agustin; Sri Wahyuni; Nur Mukarromah
Indonesian Academia Health Sciences Journal Vol 6 No 1 (2025): INDONESIAN ACADEMIA HEALTH SCIENCES JOURNAL
Publisher : Faculty of Health Sciences, Universitas Muhammadiyah Surabaya, East Java, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30651/inahes.v6i1.26579

Abstract

Diabetes Mellitus (DM) is one of the risk factors faced by COVID-19 patients. diabetics aged >60 years, uncontrolled blood sugar levels, and the presence of complications from diabetes with a poor COVID-19 prognosis. In China, the death percentage of diabetics who contracted COVID-19 was 7.3%. In Italy, 36% of deaths in COVID-19 patients are related to diabetes. This study aims to analyze a comprehensive summary of the article Comorbid Diabetes Mellitus in Coronavirus Disease (COVID-19) Patients. Using the literature review method. PubMed, Science Direct and Medica Hospitalia databases. Inclusion criteria: articles on comorbid diabetes mellitus in COVID-19 patients, causes and effects on comorbid diabetes in COVID-19 patients, years from the end of 2019 to 2021, using English and Indonesian, Journal Article and Research article types, availability abstract and full text, Medline journal category. keyword Diabetes Mellitus, COVID-19 obtained 10 articles. COVID-19 patients with diabetes mellitus exhibit a wide range of severity, many of which weigh. Factors whose severity is characterized by age ranging from 50 to 70 years, a history of hypertension, signs and symptoms that are often experienced by COVID-19 patients with diabetes are dyspnea and weakness, laboratory findings show an increase in neutrophils, C-protein reactive, erythrocyte sedimentation rate, procalcitonin, D-dimer, and decreased lymphocytes and albumin. The radiological findings showed a picture of bilateral pneumonia on CT-scan results. The severity and mortality rates vary widely, the severity ranges from 11.1% to 42.4%, and the mortality rate ranges from 15.4% to 42.9%. Comorbidities of diabetes mellitus can increase the severity of COVID-19 patients, there are factors that are related to age, hypertension, symptoms of dyspnea and weakness, inflammation, increased coagulation activity, bilateral pneumonia, high severity and mortality.
Comorbid Diabetes Mellitus in Patients with Coronavirus Disease 2019: A Literature Review Suyatno Hadi Saputro; Ratna Agustin; Sri Wahyuni; Nur Mukarromah
Indonesian Academia Health Sciences Journal Vol 6 No 1 (2025): INDONESIAN ACADEMIA HEALTH SCIENCES JOURNAL
Publisher : Faculty of Health Sciences, Universitas Muhammadiyah Surabaya, East Java, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30651/inahes.v6i1.26579

Abstract

Diabetes Mellitus (DM) is one of the risk factors faced by COVID-19 patients. diabetics aged >60 years, uncontrolled blood sugar levels, and the presence of complications from diabetes with a poor COVID-19 prognosis. In China, the death percentage of diabetics who contracted COVID-19 was 7.3%. In Italy, 36% of deaths in COVID-19 patients are related to diabetes. This study aims to analyze a comprehensive summary of the article Comorbid Diabetes Mellitus in Coronavirus Disease (COVID-19) Patients. Using the literature review method. PubMed, Science Direct and Medica Hospitalia databases. Inclusion criteria: articles on comorbid diabetes mellitus in COVID-19 patients, causes and effects on comorbid diabetes in COVID-19 patients, years from the end of 2019 to 2021, using English and Indonesian, Journal Article and Research article types, availability abstract and full text, Medline journal category. keyword Diabetes Mellitus, COVID-19 obtained 10 articles. COVID-19 patients with diabetes mellitus exhibit a wide range of severity, many of which weigh. Factors whose severity is characterized by age ranging from 50 to 70 years, a history of hypertension, signs and symptoms that are often experienced by COVID-19 patients with diabetes are dyspnea and weakness, laboratory findings show an increase in neutrophils, C-protein reactive, erythrocyte sedimentation rate, procalcitonin, D-dimer, and decreased lymphocytes and albumin. The radiological findings showed a picture of bilateral pneumonia on CT-scan results. The severity and mortality rates vary widely, the severity ranges from 11.1% to 42.4%, and the mortality rate ranges from 15.4% to 42.9%. Comorbidities of diabetes mellitus can increase the severity of COVID-19 patients, there are factors that are related to age, hypertension, symptoms of dyspnea and weakness, inflammation, increased coagulation activity, bilateral pneumonia, high severity and mortality.